Juan Francisco Peris-Martí, Elia M Fernández-Villalba, Patricia Bravo-José, Carmen Isabel Sáez-Lleó, Minerva Espert-Roig, Pilar Martínez-Antequera
{"title":"Design and validation of IF-CSS frailty index based on the comprehensive geriatric assessment for its application in nursing homes.","authors":"Juan Francisco Peris-Martí, Elia M Fernández-Villalba, Patricia Bravo-José, Carmen Isabel Sáez-Lleó, Minerva Espert-Roig, Pilar Martínez-Antequera","doi":"10.1016/j.farma.2025.06.002","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To validate the IF-CSS frailty index according to its predictive capacity for mortality and to define the intervals compatible with frailty states.</p><p><strong>Methods: </strong>An observational, retrospective, multicenter study of a cohort of elderly patients from four nursing homes with a follow up between 12 and 38 months was conducted. The IF-CSS comprised 17 variables across four domains from the comprehensive geriatric assessment. Contrast of hypothesis log-rank for survival curves according to IF-CSS index was performed. The predictive model of survival time was performed using a parametric accelerated failure model.</p><p><strong>Results: </strong>535 patients with a mean age of 83.62 years (DE±7.84) were included. Mortality rate during the study period was 39.8%. Survival curves by frailty intervals showed significant differences (χ<sup>2</sup> = 92; p < 0.001). The comparative analysis also showed significant differences for almost all the variables included in the construct. The parametric model of accelerated failure estimated a 29% reduction in survival time for each tenth of an increase in the IF-CSS.</p><p><strong>Conclusions: </strong>The IF-CSS results in a tool with a frailty discriminative and mortality predictive capacity that allows its use in the care programs of nursing homes.</p>","PeriodicalId":45860,"journal":{"name":"FARMACIA HOSPITALARIA","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FARMACIA HOSPITALARIA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.farma.2025.06.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To validate the IF-CSS frailty index according to its predictive capacity for mortality and to define the intervals compatible with frailty states.
Methods: An observational, retrospective, multicenter study of a cohort of elderly patients from four nursing homes with a follow up between 12 and 38 months was conducted. The IF-CSS comprised 17 variables across four domains from the comprehensive geriatric assessment. Contrast of hypothesis log-rank for survival curves according to IF-CSS index was performed. The predictive model of survival time was performed using a parametric accelerated failure model.
Results: 535 patients with a mean age of 83.62 years (DE±7.84) were included. Mortality rate during the study period was 39.8%. Survival curves by frailty intervals showed significant differences (χ2 = 92; p < 0.001). The comparative analysis also showed significant differences for almost all the variables included in the construct. The parametric model of accelerated failure estimated a 29% reduction in survival time for each tenth of an increase in the IF-CSS.
Conclusions: The IF-CSS results in a tool with a frailty discriminative and mortality predictive capacity that allows its use in the care programs of nursing homes.
期刊介绍:
Una gran revista para acceder a los mejores artículos originales y revisiones de la farmacoterapia actual. Además, es Órgano de expresión científica de la Sociedad Española de Farmacia Hospitalaria, y está indexada en Index Medicus/Medline, EMBASE/Excerpta Médica, Alert, Internacional Pharmaceutical Abstracts y SCOPUS.